Assenagon Asset Management’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
196,659
-277,034
| -58% | -$1.99M | ﹤0.01% | 831 |
|
|
2025
Q1 | $2.84M | Hold |
473,693
| – | – | ﹤0.01% | 646 |
|
|
2024
Q4 | $3.69M | Sell |
473,693
-133,515
| -22% | -$1.04M | 0.01% | 741 |
|
|
2024
Q3 | $6.56M | Buy |
607,208
+6,444
| +1% | +$69.6K | 0.01% | 617 |
|
|
2024
Q2 | $5.06M | Hold |
600,764
| – | – | 0.01% | 609 |
|
|
2024
Q1 | $4.04M | Hold |
600,764
| – | – | 0.01% | 633 |
|
|
2023
Q4 | $3.53M | Sell |
600,764
-8,134
| -1% | -$47.8K | 0.01% | 709 |
|
|
2023
Q3 | $5.94M | Sell |
608,898
-89,373
| -13% | -$871K | 0.02% | 508 |
|
|
2023
Q2 | $8.27M | Hold |
698,271
| – | – | 0.03% | 369 |
|
|
2023
Q1 | $7.53M | Hold |
698,271
| – | – | 0.03% | 438 |
|
|
2022
Q4 | $8.07M | Sell |
698,271
-290,365
| -29% | -$3.36M | 0.03% | 393 |
|
|
2022
Q3 | $14.8M | Hold |
988,636
| – | – | 0.06% | 260 |
|
|
2022
Q2 | $8.92M | Buy |
+988,636
| New | +$8.92M | 0.03% | 373 |
|